Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 1상모집 예정· Large B-cell Lymphoma재발 및 불응성 중추신경계 림프종에 대한 골카도마이드, 페메트렉시드, 리투시맙, 덱사메타손 병용 치료
Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas
협력: BMS
- 1상모집 예정· Healthy Female Participants건강한 여성 참여자에서 [14C]Navlimetostat (BMS-986504)의 대사, 배설 경로 및 범위, 약물 농도를 평가하는 연구
A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants
리드: BMS
- 1상모집 예정· AQP4+ NMOSD아쿠아포린-4 항체 양성 신경척수염광학신경염 환자를 대상으로 한 CC-97540(BMS-086353)의 안전성 및 내약성 연구
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
협력: BMS
- 1상모집 예정· Healthy Female Adults건강한 참여자에서 나브리메토스타트(BMS-986504)의 약물 상호작용 및 음식 영향 연구
A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants
리드: BMS
- 1상모집 예정· Kidney Failure, Chronic신기능 정상자와 비교한 중증 신장애 및 말기 신부전 환자에서 골카도마이드의 약동학 및 안전성 평가 연구
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
리드: BMS
- 1상모집 예정· Alzheimer's Disease건강한 성인의 단일 투여 후 및 초기 알츠하이머병 환자의 반복 투여 후 BMS-986446의 약물 농도, 절대 생체이용률, 안전성, 허용성 및 면역원성 평가 연구
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
리드: BMS
- 1상모집 중· Healthy Volunteers건강한 사람에서 BMS-986533의 안전성, 약동학, 음식·pH 효과 및 약물상호작용 평가 연구
Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants
리드: BMS
- 1상모집 예정· KMT2A-rearranged재발성 또는 불응성 급성골수성백혈병을 가진 청소년 및 성인에서 Ziftomenib + Mezigdomide 병합 투여 연구
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
협력: BMS
- 1상모집 중· Healthy Volunteers건강한 성인 참가자에서 BMS-986521에 의한 M4 무스카린 아세틸콜린 수용체 점유도 평가를 위한 양전자방출단층촬영 연구
A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants
리드: BMS
- 1상모집 중· Healthy Participants나블리메토스타트 정제 제형의 임상 1상 연구
A Phase 1 Study of Navlimetostat Tablet Formulations
리드: BMS
- 1상모집 중· Colorectal Cancer진행성 위장관암에서 DISP-10의 1상 임상시험
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
협력: BMS
- 1상모집 중· Diffuse Pleural Mesothelioma고형암 환자에서 BMS-986504와 표준 치료의 병용 연구
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
협력: BMS
- 1상모집 중· Rheumatoid ArthritisA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
리드: BMS
- 1상완료· Healthy VolunteersA Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants
리드: BMS
- 1상모집 중· Renal Cell CarcinomaA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
리드: BMS
- 1상모집 중· Healthy VolunteersA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
리드: BMS
- 1상모집 중· Advanced Solid TumorsA Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors
리드: BMS
- 1상완료· Healthy VolunteersA Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
협력: BMS
- 1상모집 중· Refractory Autoimmune DiseasesA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
리드: BMS
- 1상모집 중· SchizophreniaA Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
리드: BMS
- 1상모집 중· Multiple MyelomaA Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
협력: BMS
- 1상모집 중· Advanced Solid TumorA Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
리드: BMS
- 1상모집 중· Healthy VolunteersA Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending Doses
리드: BMS
- 1상모집 중단 (진행 중)· Small Cell Lung CarcinomaA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer
리드: BMS
- 1상모집 중· Advanced Malignant TumorsA Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
리드: BMS
- 1상모집 중· Advanced Solid Tumors With Homozygous MTAP DeletionA Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion
리드: BMS
- 1상모집 중단 (진행 중)· Advanced Solid TumorsA Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
리드: BMS
- 1상모집 중· High-grade Serous Ovarian Carcinoma (HGSOC)A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
리드: BMS
- 1상모집 중단 (진행 중)· Multiple MyelomaA Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
리드: 화이자 · 협력: BMS
- 1상모집 중· B-Cell Non-Hodgkin Lymphoma-RecurrentCC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
협력: BMS
- 1상모집 중· Relapsed and/or Refractory Multiple MyelomaA Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
리드: BMS
- 1상모집 중· Metastatic Castration-resistant Prostate CancerA Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
리드: BMS
- 1상모집 중단 (진행 중)· Systemic Lupus ErythematosusA Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
리드: BMS
- 1상모집 중단 (진행 중)· DLBCL - Diffuse Large B Cell LymphomaLow Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
협력: BMS
- 1상모집 중· Multiple MyelomaA Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
협력: BMS
- 1상모집 중단 (진행 중)· Classical Hodgkin LymphomaAutologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
협력: BMS
- 1상모집 중단 (진행 중)· Multiple MyelomaCPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
협력: BMS
- 1상모집 중· Solid TumorStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
협력: BMS
- 1상모집 중단 (진행 중)· Hepatocellular CarcinomaFeasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
협력: BMS
- 1상모집 중단 (진행 중)· Advanced Solid TumorStudy of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours
협력: BMS
- 1상모집 중단 (진행 중)· Pancreatic Ductal AdenocarcinomaA Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
협력: BMS
- 1상모집 중단 (진행 중)· Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC
협력: BMS
- 1상모집 중단 (진행 중)· Recurrent GlioblastomaIL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
협력: BMS
- 1상모집 중단 (진행 중)· Malignant Pleural MesotheliomaA Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
협력: BMS
- 1상모집 중단 (진행 중)· OsteosarcomaNivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
협력: BMS
- 1상모집 중단 (진행 중)· Pathologic Stage IIIB Cutaneous Melanoma AJCC v8VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma
협력: BMS
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.